Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention

Molecular Nutrition and Food Research

Volumn 57, Issue 6, 2013, Pages 962-973

  Llorach, Rafael ^a,b   Urpi Sarda, Mireia ^a   Tulipani, Sara ^a,b,c   Garcia Aloy, Mar ^a,b   Monagas, Maria ^b,d   Andres Lacueva, Cristina ^a,b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ministry of Science and Innovation   (Spain)

^c Hospital University Carlos Haya de Málaga   (Spain)

^d INSTITUTE OF FOOD SCIENCE RESEARCH CIAL   (Spain)

Author keywords

Carnitine metabolism; Cocoa intervention; Metabolomics; Polyphenols metabolism; Tyrosine O sulfate

Indexed keywords

BIOLOGICAL MARKER; PLANT MEDICINAL PRODUCT;

AGED; ARTICLE; BLOOD; CACAO; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; HUMAN; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; URINE;

AGED; BIOLOGICAL MARKERS; CACAO; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; METABOLOMICS; MULTIVARIATE ANALYSIS; PHYTOCHEMICALS;

THEOBROMA CACAO;

EID: 84878925814     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201200736     Document Type: Article

References (63)

1. Wishart, D., Metabolomics: applications to food science and nutrition research. Trends Food Sci. Technol. 2008, 19, 482-493.
2. Morris, C., O'Grada, C., Ryan, M., Roche, H. M. et al., The relationship between BMI and metabolomic profiles: a focus on amino acids. Proc. Nutr. Soc. 2012, 71, 634-638.
3. Manach, C., Hubert, J., Llorach, R., Scalbert, A., The complex links between dietary phytochemicals and human health deciphered by metabolomics. Mol. Nutr. Food Res. 2009, 53, 1303-1315.
4. McGhie, T. K., Rowan, D. D., Metabolomics for measuring phytochemicals, and assessing human and animal responses to phytochemicals, in food science. Mol. Nutr. Food Res. 2012, 56, 147-158.
5. Herrero, M., Simo, C., Garcia-Canas, V., Ibanez, E. et al., Foodomics: MS-based strategies in modern food science and nutrition. Mass Spectrom. Rev. 2012, 31, 49-69.
6. Buijsse, B., Feskens, E. J., Kok, F. J., Kromhout, D., Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch. Intern. Med. 2006, 166, 411-417.
7. Kris-Etherton, P. M., Keen, C. L., Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr. Opin. Lipidol. 2002, 13, 41-49.
8. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38-50.
9. Ding, E. L., Hutfless, S. M., Ding, X., Girotra, S., Chocolate and prevention of cardiovascular disease: a systematic review. Nutr. Metab. (Lond.). 2006, 3, 2-14.
10. Mao, T. K., Powell, J., Van de Water, J., Keen, C. L. et al., The effect of cocoa procyanidins on the transcription and secretion of interleukin 1 beta in peripheral blood mononuclear cells. Life Sci. 2000, 66, 1377-1386.
11. Sanbongi, C., Suzuki, N., Sakane, T., Polyphenols in chocolate, which have antioxidant activity, modulate immune functions in humans in vitro. Cell Immunol. 1997, 177, 129-136.
12. Allen, R. R., Carson, L., Kwik-Uribe, C., Evans, E. M. et al., Daily consumption of a dark chocolate containing flavanols and added sterol esters affects cardiovascular risk factors in a normotensive population with elevated cholesterol. J. Nutr. 2008, 138, 725-731.
13. Farouque, H. M., Leung, M., Hope, S. A., Baldi, M. et al., Acute and chronic effects of flavanol-rich cocoa on vascular function in subjects with coronary artery disease: a randomized double-blind placebo-controlled study. Clin. Sci. (Lond.). 2006, 111, 71-80.
14. Wang-Polagruto, J. F., Villablanca, A. C., Polagruto, J. A., Lee, L. et al., Chronic consumption of flavanol-rich cocoa improves endothelial function and decreases vascular cell adhesion molecule in hypercholesterolemic postmenopausal women. J. Cardiovasc. Pharmacol. 2006, 47(Suppl 2), S177-S186; discussion S206-S179.
15. Hooper, L., Kay, C., Abdelhamid, A., Kroon, P. A. et al., Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740-751.
16. Khan, N., Monagas, M., Andres-Lacueva, C., Casas, R. et al., Regular consumption of cocoa powder with milk increases HDL cholesterol and reduces oxidized LDL levels in subjects at high-risk of cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 1046-1053.
17. Monagas, M., Khan, N., Andres-Lacueva, C., Casas, R. et al., Effect of cocoa powder on the modulation of inflammatory biomarkers in patients at high risk of cardiovascular disease. Am. J. Clin. Nutr. 2009, 90, 1144-1150.
18. Singleton, V., Rossi, J., Colorimetry of total phenolics with phosphomolibdicphosphotungstic acid reagent. Am. J. Enol. Vitic. 1965, 16, 144-158.
19. Ribéreau-Gayon, P., Stonestreet, E., Dosage des tannins du vin rouges et détermination du leur structure. Chim. Anal. 1966, 48, 188-196.
20. Andres-Lacueva, C., Monagas, M., Khan, N., Izquierdo-Pulido, M. et al., Flavanol and flavonol contents of cocoa powder products: influence of the manufacturing process. J. Agric. Food Chem. 2008, 56, 3111-3117.
21. Monagas, M., Gomez-Cordoves, C., Bartolome, B., Laureano, O. et al., Monomeric, oligomeric, and polymeric flavan-3-ol composition of wines and grapes from Vitis vinifera L. Cv. Graciano, Tempranillo, and Cabernet Sauvignon. J. Agric. Food Chem. 2003, 51, 6475-6481.
22. Llorach, R., Urpi-Sarda, M., Jauregui, O., Monagas, M. et al., An LC-MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. J. Proteome Res. 2009, 8, 5060-5068.
23. Carter, M. D., Southwick, K., Lukov, G., Willardson, B. M. et al., Identification of phosphorylation sites on phosducin-like protein by QTOF mass spectrometry. J. Biomol. Tech. 2004, 15, 257-264.
24. Wiklund, S., Johansson, E., Sjostrom, L., Mellerowicz, E. J. et al., Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 2008, 80, 115-122.
25. Kutyniok, M., Muller, C., Crosstalk between above- and belowground herbivores is mediated by minute metabolic responses of the host Arabidopsis thaliana. J. Exp. Botany. 2012, 63, 6199-6210.
26. Eriksson, L., Trygg, J., Wold, S., CV-ANOVA for significance testing of PLS and OPLS® models. J. Chemom. 2008, 22, 594-600.
27. Zhao, Y., Wang, H., Gustafsson, M., Muraro, A. et al., Combined multivariate and pathway analyses show that allergen-induced gene expression changes in CD4+ T cells are reversed by glucocorticoids. PLoS ONE 2012, 7, e39016.
28. Brindle, J. T., Antti, H., Holmes, E., Tranter, G. et al., Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 2002, 8, 1439-1444.
29. Kang, J., Choi, M. Y., Kang, S., Kwon, H. N. et al., Application of a 1H nuclear magnetic resonance (NMR) metabolomics approach combined with orthogonal projections to latent structure-discriminant analysis as an efficient tool for discriminating between Korean and Chinese herbal medicines. J. Agric. Food Chem. 2008, 56, 11589-11595.
30. Tulipani, S., Llorach, R., Jauregui, O., Lopez-Uriarte, P. et al., Metabolomics unveils urinary changes in subjects with metabolic syndrome following 12-week nut consumption. J. Proteome Res. 2011, 10, 5047-5058.
31. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R. et al., HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res. 2009, 37, D603-D610.
32. Tautenhahn, R., Cho, K., Uritboonthai, W., Zhu, Z. et al., An accelerated workflow for untargeted metabolomics using the METLIN database. Nat. Biotechnol. 2012, 30, 826-828.
33. Horai, H., Arita, M., Kanaya, S., Nihei, Y. et al., MassBank: a public repository for sharing mass spectral data for life sciences. J. Mass Spectrom. 2010, 45, 703-714.
34. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. et al., KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012, 40, D109-D114.
35. Rothwell, J. A., Urpi-Sarda, M., Boto-Ordonez, M., Knox, C. et al., Phenol-Explorer 2.0: a major update of the Phenol-Explorer database integrating data on polyphenol metabolism and pharmacokinetics in humans and experimental animals. Database (Oxford) 2012, 2012, bas031.
36. Caraux, G., Pinloche, S., PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order. Bioinformatics. 2005, 21, 1280-1281.
37. Metabolomics-Fiehn-Lab mass spectrometry mass calculator. Available from: http://fiehnlab.ucdavis.edu/staff/kind/Metabolomics/MS-Adduct-Calculator.
38. Levsen, K., Schiebel, H.-M., Behnke, B., Dötzer, R. et al., Structure elucidation of phase II metabolites by tandem mass spectrometry: an overview. J. Chromatogr. A 2005, 1067, 55-72.
39. Wolf, S., Schmidt, S., Muller-Hannemann, M., Neumann, S., In silico fragmentation for computer assisted identification of metabolite mass spectra. BMC Bioinformatics 2010, 11, 148-160.
40. Suhre, K., Schmitt-Kopplin, P., MassTRIX: mass translator into pathways. Nucleic Acids Res. 2008, 36, W481-W484.
41. Rolinski, B., Arnecke, R., Dame, T., Kreischer, J. et al., The biochemical metabolite screen in the Munich ENU Mouse Mutagenesis Project: determination of amino acids and acylcarnitines by tandem mass spectrometry. Mamm. Genome 2000, 11, 547-551.
42. Urpi-Sarda, M., Monagas, M., Khan, N., Llorach, R. et al., Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258-7267.
43. Baba, S., Osakabe, N., Natsume, M., Muto, Y. et al., In vivo comparison of the bioavailability of (+)-catechin, (-)-epicatechin and their mixture in orally administered rats. J. Nutr. 2001, 131, 2885-2891.
44. Baba, S., Osakabe, N., Yasuda, A., Natsume, M. et al., Bioavailability of (-)-epicatechin upon intake of chocolate and cocoa in human volunteers. Free Radic. Res. 2000, 33, 635-641.
45. Llorach, R., Garrido, I., Monagas, M., Urpi-Sarda, M. et al., Metabolomics study of human urinary metabolome modifications after intake of almond (Prunus dulcis (Mill.) D.A. Webb) skin polyphenols. J. Proteome Res. 2010, 9, 5859-5867.
46. Urpi-Sarda, M., Llorach, R., Khan, N., Monagas, M. et al., Effect of milk on the urinary excretion of microbial phenolic acids after cocoa powder consumption in humans. J. Agric. Food Chem. 2010, 58, 4706-4711.
47. Rios, L. Y., Gonthier, M. P., Remesy, C., Mila, I. et al., Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am. J. Clin. Nutr. 2003, 77, 912-918.
48. Rodopoulos, N., Hojvall, L., Norman, A., Elimination of theobromine metabolites in healthy adults. Scand. J. Clin. Lab. Invest. 1996, 56, 373-383.
49. Stark, T., Lang, R., Keller, D., Hensel, A. et al., Absorption of N-phenylpropenoyl-L-amino acids in healthy humans by oral administration of cocoa (Theobroma cacao). Mol. Nutr. Food Res. 2008, 52, 1201-1214.
50. Stark, T., Bareuther, S., Hofmann, T., Molecular definition of the taste of roasted cocoa nibs (Theobroma cacao) by means of quantitative studies and sensory experiments. J. Agric. Food Chem. 2006, 54, 5530-5539.
51. Afoakwa, E. O., Paterson, A., Fowler, M., Ryan, A., Matrix effects on flavour volatiles release in dark chocolates varying in particle size distribution and fat content using GC-mass spectrometry and GC-olfactometry. Food Chem. 2009, 113, 208-215.
52. Ranasinghe, J. G., Sakakibara, Y., Harada, M., Nishiyama, K. et al., Structural identification of sulfated tyrosine in human urine. Biosci. Biotechnol. Biochem. 1999, 63, 229-231.
53. Liu, J., Louie, S., Hsu, W., Yu, K. M. et al., Tyrosine sulfation is prevalent in human chemokine receptors important in lung disease. Am. J. Respir. Cell Mol. Biol. 2008, 38, 738-743.
54. Hext, P. M., Thomas, S., Rose, F. A., Dodgson, K. S., Determination and significance of l-tyrosine O-sulphate and its deaminated metabolites in normal human and mouse urine. Biochem. J. 1973, 134, 629-635.
55. Tauxe, C., Xie, X., Joffraud, M., Martinez, M. et al., P-selectin glycoprotein ligand-1 decameric repeats regulate selectin-dependent rolling under flow conditions. J. Biol. Chem. 2008, 283, 28536-28545.
56. Barazzoni, R., Zanetti, M., Davanzo, G., Kiwanuka, E. et al., Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations. J. Clin. Endocrinol. Metab. 2000, 85, 3121-3125.
57. Chiva-Blanch, G., Urpi-Sarda, M., Llorach, R., Rotches-Ribalta, M. et al., Differential effects of polyphenols and alcohol of red wine on the expression of adhesion molecules and inflammatory cytokines related to atherosclerosis: a randomized clinical trial. Am. J. Clin. Nutr. 2012, 95, 326-334.
58. Norata, G. D., Marchesi, P., Passamonti, S., Pirillo, A. et al., Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007, 191, 265-271.
59. Srinivas, S. R., Prasad, P. D., Umapathy, N. S., Ganapathy, V. et al., Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0, +). Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293, G1046-G1053.
60. Sugiyama, N., Kidouchi, K., Kobayashi, M., Wada, Y., Carnitine deficiency in inherited organic acid disorders and Reye syndrome. Acta Paediatr. Jpn. 1990, 32, 410-416.
61. Roe, C. R., Millington, D. S., Maltby, D. A., Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. J. Clin. Invest. 1986, 77, 1391-1394.
62. Mels, C. M., Jansen van Rensburg, P., van der Westhuizen, F. H., Pretorius, P. J. et al., Increased excretion of c4-carnitine species after a therapeutic acetylsalicylic acid dose: evidence for an inhibitory effect on short-chain Fatty Acid metabolism. ISRN Pharmacol. 2011, 2011, 851870.
63. Murase, T., Nagasawa, A., Suzuki, J., Hase, T. et al., Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int. J. Obes. Relat. Metab. Disord. 2002, 26, 1459-1464.